Lyell Immunopharma

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LYEL and other ETFs, options, and stocks.

About LYEL

Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D.

CEO

Lynn Seely

CEOLynn Seely

Employees

300

Employees300

Headquarters

South San Francisco, California

HeadquartersSouth San Francisco, California

Founded

2018

Founded2018

Employees

300

Employees300

LYEL Key Statistics

Market cap

189.10M

Market cap189.10M

Price-Earnings ratio

-0.51

Price-Earnings ratio-0.51

Dividend yield

—

Dividend yield—

Average volume

350.77K

Average volume350.77K

High today

$13.73

High today$13.73

Low today

$10.87

Low today$10.87

Open price

$11.42

Open price$11.42

Volume

383.80K

Volume383.80K

52 Week high

$53.50

52 Week high$53.50

52 Week low

$7.65

52 Week low$7.65

People also own

Based on the portfolios of people who own LYEL. This list is generated using Robinhood data, and it’s not a recommendation.